Table 4 of Tanwar, Mol Vis 2010; 16:518-533.
Gene name |
Cases (n=35) |
Controls (n=40) |
p-value |
Relative risk at 95% confidence interval |
---|---|---|---|---|
ND1 | 6 (17.14%) | 2 (5.0%) | 0.136 | 1.73 (1.07–2.81) |
ND2 | 10 (28.57%) | 2 (5.0%) | 0.005 | 2.10 (1.41–3.12) |
ND3 | 17 (48.60%) | 0 (0%) | <0.001 | 3.22 (2.19–4.72) |
ND4 | 0 (0%) | 0 (0%) | —- | —– |
ND4L | 0 (0%) | 2 (5.0%) | 0.495 | 1.92 (1.54–2.39) |
ND5 | 21 (60.00%) | 4 (10.0%) | <0.001 | 3.00 (1.86–4.83) |
CO1 | 4 (11.42%) | 0 (0%) | 0.043 | 2.29 (1.75–2.98) |
CO2 | 5 (14.30%) | 0 (0%) | 0.019 | 2.33 (1.78–3.05) |
CO3 | 1 (2.90%) | 0 (0%) | 0.467 | 2.17 (1.70–2.78) |
CYB | 4 (11.42%) | 8 (20.00%) | 0.360 | 0.57 (0.18–1.73) |
ATPase6 | 18 (51.42%) | 7 (17.50%) | 0.002 | 2.12 (1.34–3.34) |
ATPase8 | 1 (2.85%) | 1 (2.5) | 1.00 | 1.07 (0.26–4.40) |
Others | 8 (22.85%) | 0 (0%) | 0.001 | 2.48 (1.85–3.32) |